Global Cephalosporin Drugs Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

The global cephalosporin drugs market size was valued at USD 12304.1 million in 2020 and is estimated to reach USD 16217.4 million by 2030, growing at a CAGR of 2.8% during the forecast period.Cephalosporins are a type of antibiotic commonly known as beta-lactam antibiotic. Cephalosporin was first prepared from a fungus named cephalosporium acremonium by scientist Dr. Abraham in 1948. A Cephalosporin Drugs is a group of semi-synthetic, wide-spectrum antibiotics mainly used to treat infections of bacteria. Cephalosporin Drugs are categorized based on the category of bacteria against which they are most efficient. Cephalosporin drugs are considered broad-spectrum antibiotics having similar activities to those of ampicillin and often are considered an alternative to penicillin for many patients. Cephalosporin drugs are used to treat infections in different parts of the body such as the lungs, ears, sinuses, nose, throat, and skin. Physicians also prescribe these drugs to treat pneumonia, staph infections, bronchitis, strep throat, tonsillitis, and gonorrhea. Various organizations around the world are taking initiatives to improve the development and delivery of antibiotic treatments. One such program is the Global Antibiotic Research and Development Partnership (GARDP), which is a not-for-profit R&D organization formed by the Drugs for Neglected Disease initiative (DNDi) and World Health Organization (WHO). It focusses on the promotion of public-private partnerships for increasing R&D of new antimicrobial diagnostics and agents
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/toc-request/DFS020186
Market Dynamics and Factors:
The major factors contributing to the growth of the cephalosporin drugs market include an increase in the percentage of the population suffering from pneumonia, tonsillitis, bronchitis, and gonorrhea. In addition, an increase in R&D activities to develop highly efficient & safe drugs and an upsurge in the use of combination therapies has boosted the market growth. However, side effects associated with cephalosporin and the development of drug-resistant bacterial strains have restrained market growth. Furthermore, increasing demand for the antibacterial drives the global cephalosporin drugs market to grow further.
Market Segmentation:
Global Cephalosporin Drugs Market – By Generation
First-generation
Second-generation
Third-generation
Fourth-generation
Fifth-generation
Global Cephalosporin Drugs Market – By Type
Branded
Generics
Global Cephalosporin Drugs Market – By Route of Drug Administration
Injection
Oral
Global Cephalosporin Drugs Market – By Application
Respiratory Tract Infection
Skin Infection
Ear Infection
Urinary Tract Infection
Sexually Transmitted Infection
Global Cephalosporin Drugs Market – By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/speak-analyst/DFS020186
Geographic Analysis:
The global cephalosporin drugs market is expected to grow largely due to increasing demand for anti-microbial in various evidence, rising research and development activities, growing awareness among patients, increasing prevalence of infectious diseases, and special regulatory designation for pipeline molecule. India and China collectively contributed to more than 40% share of the Asia-Pacific cephalosporin market in 2017. The respiratory tract infection segment generated the highest revenue in 2017 and is anticipated to maintain its dominance throughout the forecast period, as cephalosporin is used for the treatment of both upper & lower respiratory tract infections and lower respiratory infections are the leading infectious causes of death globally.
Competitive Scenario:
The key players in the market are ABBOTT Laboratories, Teva Pharmaceuticals Industries Ltd., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer Inc., Merck & Co. Inc., Bayer AG, Baxter International Inc., Bristol-Myers Squibb Company, Novartis AG, Astellas, Roche, Bristol-Myers Squibb, Lupin Pharmaceuticals, Ranbaxy, Sandoz, and Teva Pharmaceuticals.
Connect to Analyst @
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Cephalosporin Drugs industry, although key threats, opportunities and disruptive technologies that could shape the Global Cephalosporin Drugs Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Cephalosporin Drugs Market most.
The data analysis present in the Global Cephalosporin Drugs Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Cephalosporin Drugs Market business.
The 2021 Annual Global Cephalosporin Drugs Market offers:
100+ charts exploring and analysing the Global Cephalosporin Drugs Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Cephalosporin Drugs Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020186
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/